Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Anim Health Prod ; 41(8): 1765-71, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19468854

ABSTRACT

A cross-sectional study was conducted in Uganda between November 2006 and February 2007 to assess the seroprevalence and risk of brucellosis in zerograzing and pastoral dairy systems; two major sources of milk in Uganda, 80% of which is sold unpasteurized to consumers through informal channels. A total of 723 cattle comprised of 497 animals from the pastoral system and 226 animals from the zerograzing system were tested for antibodies against natural B. abortus infection using the competitive enzyme-linked immunosorbent assay (C-ELISA). Herd-level seroprevalence was 100% in the pastoral system and 5.5% (95% CI: 1.8, 9.2) in the zerograzing system. The animal-level seroprevalence and within-herd range of brucellosis in cattle in the pastoral system were 34.0% (95% CI: 29.9, 38.1) and 8.1-75.9%, while for those in the zerograzing system were 3.3% (95% CI: 0.9, 5.7) and 0-9.0%. Abortion rates of 23% and 0% among seropositive cows vis-à-vis 5.4% and 1.9% among seronegative cows were recorded in the pastoral and zerograzing systems, respectively. The risk of natural B. abortus infection was higher among older cattle (>24 m) (Odds ratio [OR] = 1.83, 95% CI: 1.25-2.67) and dry cows (OR = 2.01, 95% CI: 1.23-3.31) in the pastoral system, and in calves aged 0-6 m (OR = 5.72, 95% CI: 1.04-31.41) in the zerograzing system. Implementing a culling program in the zerograzing system to eliminate the existing low risk of brucellosis and targeting calves in the pastoral systems for vaccination could avert the cost-related limitation of brucellosis control in Uganda.


Subject(s)
Animal Husbandry/methods , Brucellosis, Bovine/epidemiology , Animals , Cattle , Cross-Sectional Studies , Dairying , Enzyme-Linked Immunosorbent Assay , Female , Logistic Models , Male , Seroepidemiologic Studies , Uganda/epidemiology
2.
Trop Anim Health Prod ; 37(1): 25-31, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15729895

ABSTRACT

A locally-produced Newcastle disease (ND) I-2 thermostable vaccine of embryo-infective dose (EID50) 10(8.5) per ml was administered to 100 laboratory chickens in four test groups, each of 25 birds. It was given by the eye-drop method, in drinking water, in drinking water freshly medicated with levamisole, or using millet grains as a vaccine carrier. A fifth control group consisting of 25 birds received the heat-sensitive La Sota vaccine (EID50 10(9) per ml) by the eye-drop method. The immunological responses were monitored by the enzyme-linked immunosorbent assay (ELISA) ND antibody technique using serum samples collected from 18 birds in each group at 3-week intervals for 3 months. The overall mean ND antibody log(10) titres and percentage positivities were 3.1, 88%; 2.9, 70%; 3.0, 83%; 3.2, 87% and 3.3, 87%, respectively. The use of water alone or medicated with levamisole for vaccine administration produced significantly lower ND antibody titres only in the first 3 weeks. The immunogenicity shown by the I-2 vaccine as a potential vaccine is discussed in relation to free-range poultry management conditions in Uganda.


Subject(s)
Antibodies, Viral/biosynthesis , Chickens , Newcastle Disease/prevention & control , Newcastle disease virus/immunology , Poultry Diseases/prevention & control , Viral Vaccines/administration & dosage , Adjuvants, Immunologic/pharmacology , Animals , Drinking , Drug Administration Routes/veterinary , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/veterinary , Levamisole/pharmacology , Ophthalmic Solutions/administration & dosage , Specific Pathogen-Free Organisms , Uganda , Vaccination/veterinary , Viral Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...